Copyright held by the owner/author(s).
1Integrated Bioanalysis, Clinical Pharmacology and Safety Sciences, R&D, AstraZeneca, Cambridge, United Kingdom.
1Division of Molecular Pathology, Netherlands Cancer Institute, Amsterdam, the Netherlands. 5Department of Pathology, Netherlands Cancer Institute – Antoni van Leeuwenhoek Hospital, Amsterdam, the ...
1CRUK Cambridge Institute, University of Cambridge. Li Ka Shing Centre, Cambridge, United Kingdom.
School of Medicine, University of Leeds, Leeds, United Kingdom. *Corresponding Author: Mihaela Lorger, School of Medicine, University of Leeds, Beckett Street ...
The Cancer Discovery editors wish to acknowledge with sincere appreciation the assistance of the following reviewers who have generously contributed their time and effort during the past year 1 in the ...
Pacific Northwest Research Institute, Seattle, Washington.
Search for other works by this author on: ...
1Sanford Research, Cancer Biology and Immunotherapies Group, Sioux Falls, South Dakota. 2Sanford School of Medicine, Health Sciences Center, University of South Dakota, Sioux Falls, South Dakota.
1Department of Pathology, University of Texas Southwestern Medical Center, Dallas, Texas. 2Hamon Center for Therapeutic Oncology Research, University of Texas Southwestern Medical Center, Dallas, ...
1Cancer, Ageing and Somatic Mutation Programme, Wellcome Sanger Institute, Hinxton, United Kingdom. *Corresponding Author: Michael R. Stratton, Cancer, Ageing and ...
The Chordoma Foundation and some of its philanthropic partners announced that they will launch a competition offering $500,000 in prizes for the discovery of drugs targeting the protein TBXT, a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback